This review aimed to critically synthesize current evidence on the role of coumarins in hypertension management, integrating mechanistic insights, preclinical findings, pharmacokinetic considerations, and available clinical data.
This review systematically examines the mechanisms of major PDBIs in hypertension, focusing on their regulation of vascular function, renin-angiotensin-aldosterone system and sympathetic nervous system, water-salt homeostasis, and target organ protection.
Qiqi Deng, Yonglin Zhang, Jing Pan et al.· Phytotherapy Research· 1 citation
Although several nutraceuticals show promising blood-pressure-lowering effects, variations in dosage, formulation, bioavailability, and clinical study quality remain important limitations and further standardized, large-scale clinical trials are required to establish their long-term efficacy and safety.
Hardik Agrahari, Vimal Kumar Yadav, Akanksha Singh· GLOBAL JOURNAL OF PHARMACEUT...· 0 citations
Diabetes mellitus is associated with a persistent prothrombotic state driven by platelet hyperreactivity, endothelial dysfunction, oxidative stress, and chronic low‑grade inflammation, all of which contribute to increased cardiovascular (CV) risk. Importantly, a substantial residual thrombotic risk persists even with o...
F. Santilli, P. Simeone, R. Liani· Internal and Emergency Medic...· 0 citations
APG emerges as a promising supplementary compound for hypertension management, combining vascular, molecular, and microbiome-mediated mechanisms with a strong safety margin.
Mohammed Ajebli, M. Hebi, D. Ousaaid et al.· Pharmacology· 0 citations
Cardiovascular diseases remain a major cause of morbidity and mortality worldwide and arise from interacting disturbances in vascular function, inflammation, redox regulation, lipid and energy metabolism, mitochondrial homeostasis, cardiac remodelling, and thrombosis. Plant-derived compounds have attracted considerable...
Satyabrata Acharya· Natural Resources for Human...· 0 citations
Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide, despite significant advances in diagnostics and pharmacotherapy. This persistent burden has shifted attention toward adjunct therapeutic strategies targeting key mechanisms of myocardial and vascular injury, including oxidative stres...
T. Milivojac, Nataša Stojaković, M. Mikov et al.· Frontiers in Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.